{
  "trial_id": "NCT03213002",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Be capable of giving informed consent.",
      "label": "met"
    },
    {
      "criterion": "Have a pathology proven diagnosis of any of newly diagnosed Glioblastoma Multiforme",
      "label": "unknown"
    },
    {
      "criterion": "WHO IV",
      "label": "not_met"
    },
    {
      "criterion": "Have completed the first part of standard of care chemo-radiation (Stupp), for 6 weeks, and not started the maintenance phase of temozolomide",
      "label": "unknown"
    },
    {
      "criterion": "Agree to use effective barrier contraception while on treatment and for 2 months thereafter, if of childbearing potential",
      "label": "met"
    },
    {
      "criterion": "Have a life expectancy > 3 months",
      "label": "unknown"
    },
    {
      "criterion": "Be between the ages of 18 to 74",
      "label": "met"
    },
    {
      "criterion": "Have a performance status KPS 70 or greater",
      "label": "not_met"
    },
    {
      "criterion": "Be able to swallow pills and capsules",
      "label": "unknown"
    },
    {
      "criterion": "Be able to tolerate oral chemotherapeutic medications, with no health threatening allergies or side effects, based on lab and clinical findings",
      "label": "met"
    },
    {
      "criterion": "Have adequate bone marrow function, liver function and renal function before commencing therapy",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Prior chemotherapy with capecitabine or temozolomide for other prior malignancies.",
      "label": "triggers"
    },
    {
      "criterion": "Patients previously treated with continuous infusion 5-FU or any schedule of DTIC, which are similar to capecitabine and temozolomide, respectively, will be excluded.",
      "label": "triggers"
    },
    {
      "criterion": "Prior chemotherapies for newly diagnosed GBM or AA, other than temozolomide during radiation.",
      "label": "triggers"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT03213002",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}